Search results for: 'screen compressor post'

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

This research service analyzes the market for high content screening technologies within the United States. The market was divided into the high content screening instrumentation and high content screening reagents and assays segments. Each segment covers market trends, technology trends, competitive structure, market share analysis, revenue foreca...

09 Jul 2020  |  North America  |  Market Research

Post-pandemic Global Healthcare Market Outlook, 2020

Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’

Infographics

×

Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...

This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

The COVID-19 pandemic and the shift toward value-based care have highlighted the need for more flexible and resilient healthcare systems, creating opportunities for innovative business models. Several challenges, such as personnel burnout, the lack of experienced staff, inflation leading to increased care costs, healthcare accessibility disparities...

The pandemic years left different learnings in terms of mental and behavioral health. The isolation addressed the migration of patients with different needs and conditions from on-site treatments to digital platforms and solutions, highlighting benefits and challenges for providers and users. The main pivotal change is a new, holistic mental and be...

Globally, the difficulty in operating large hospitals is made worse by use of manual operations and processes that often lead to a host of inefficiencies. The COVID-19 pandemic in the first half of 2020 brought these inefficiencies to the fore, and as a lasting impact, hospitals must now address the backlog of outpatient, imaging, and surgery patie...